-78
NPS Score
VS
BioScrip
- EMPLOYEE
PARTICIPANTS - 7
- TOTAL
RATINGS
QuVa Pharma
- EMPLOYEE
PARTICIPANTS - 26
- TOTAL
RATINGS
BioScrip vs QuVa Pharma
Compare BioScrip versus QuVa Pharma for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 7 employees and customers of BioScrip and 26 employees and customers of QuVa Pharma.
BioScrip
BioScrip's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of BioScrip. Their current market cap is $2.95B.
QuVa Pharma
QuVa Pharma's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of QuVa Pharma. Their current valuation is $100.00M.
2.8/5
Product Quality
3.1/5
2.6/5
Pricing
3.2/5
1.8/5
Customer Service
3.2/5
| 7% | Promoters |
|---|---|
| 8% | Passive |
| 85% | Detractors |
0
NPS Score
| 50% | Promoters |
|---|---|
| 0% | Passive |
| 50% | Detractors |
Net Promoter Score
Winner by 78
See how BioScrip compares to its competitors
See how QuVa Pharma compares to its competitors
Working at BioScrip vs Working at QuVa Pharma
62 / 100
CEO Rating
Winner by 10%
52 / 100
CEO Rating
BioScrip
BioScrip doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
QuVa Pharma
Employees at QuVa Pharma rate their CEO, Stuart Hinchen, 52/100. This score is 10% lower than the scores of BioScrip's CEO, Dan Greenleaf.